Our Latest Stories

Your Health
April 11, 2025
More to the Story of CIDP: a Complex Neuromuscular Condition

United by Purpose
Each of us plays a unique role in bringing our purpose to life.
About Us

Who We Are
We are an innovative global healthcare company.
Our Pipeline
5
Therapeutic areas
86
Compounds in clinical development
24
Clinical trials in phase 3

Pursue Progress. Discover Extraordinary.
Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.
Our Latest Press Releases
April 25, 2025
Media Update: Sanofi’s Foundation S and Sobi extend their partnership with the World Federation of Hemophilia Humanitarian Aid Program
April 24, 2025
Press Release: Sanofi: strong Q1 performance and 2025 guidance confirmed
April 18, 2025
Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria
April 15, 2025
Press Release: Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD